Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)

NCT00690820 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis
Pancreatic Exocrine Insufficiency

Interventions

DRUG: Pancrelipase Delayed Release
DRUG: Placebo Comparator

Sponsor

Solvay Pharmaceuticals